Parkinson’s disease

VUMC recognized for atypical Parkinsonism care and research

Vanderbilt’s Department of Neurology has been named a CurePSP Center of Care

The certification team included, from left, Arlene Boudreaux, MSN, RN, CNRN, Ryan Schell, PharmD, BCPS, Fenna Phibbs, MD, MPH, and Jessica Stroh, RN. (photo by Donn Jones)

VUMC receives national certification for Parkinson’s disease care

Vanderbilt University Medical Center recently became the nation’s second health care organization to receive The Joint Commission’s Gold Seal of Approval for Parkinson’s Disease Certification.

Study examines impulsiveness in Parkinson’s disease

Vanderbilt researchers are studying aspects of dopamine release and its regulation in Parkinson’s patients with and without impulsive-compulsive behaviors.

photo of David Charles and Mallory Hacker

Pilot study suggests Parkinson’s disease progression can be slowed

A pair of ultra-thin electrodes surgically implanted deep into the brain might slow the progression of Parkinson’s disease, according to five-year outcomes from a 30-patient randomized clinical trial conducted by investigators at Vanderbilt University Medical Center.

Neuromodulation Society honors Hacker’s Parkinson’s research

Mallory Hacker, PhD, research assistant professor of Neurology, is the 2019 recipient of the Kumar New Investigator Award from the North American Neuromodulation Society.

photo of David Charles and Mallory Hacker

Parkinson’s study to track impact of DBS on earliest patients

A decade after taking part in the first clinical trial of deep brain stimulation (DBS) administered during very early-stage Parkinson’s disease, participants will return to Vanderbilt University Medical Center this year to be re-evaluated.

1 2 3